Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
63.2M
-
Shares change
-
+7.7M
-
Total reported value, excl. options
-
$1.8B
-
Value change
-
+$224M
-
Put/Call ratio
-
0.1
-
Number of buys
-
76
-
Number of sells
-
-56
-
Price
-
$28.53
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q3 2022
170 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2022.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.2M shares
of 75.6M outstanding shares and own 83.65% of the company stock.
Largest 10 shareholders include FMR LLC (9.36M shares), ORBIMED ADVISORS LLC (5.53M shares), Bain Capital Life Sciences Investors, LLC (4.83M shares), PERCEPTIVE ADVISORS LLC (3.47M shares), EcoR1 Capital, LLC (3.46M shares), BOXER CAPITAL, LLC (3.42M shares), STATE STREET CORP (3.32M shares), VANGUARD GROUP INC (3.2M shares), BlackRock Inc. (2.82M shares), and ArrowMark Colorado Holdings LLC (2.55M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.